Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual ...

For more information about Syncromune®, Inc. please visit www.syncromune.com.

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinityTb-161 antitumor activity driven by the dual emission ...
Rolling Out

Prostate cancer stages every Black man needs to know now

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...
FOX 10 Phoenix

Prostate cancer - symptoms, risk factors, and treatment

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...
India Today on MSN

What makes prostate cancer one of the most deadly cancers in the world

Prostate cancer is one of the leading causes of cancer deaths globally. It only affects men, and the risk of developing the ...